-
Daniel Christian Patient Advocate joined the group Regenerative Medicine Advocate Network
-
Sam DaCosta (Hoover) joined the group Regenerative Medicine Advocate Network
-
Marc S. Nehamkin joined the group Regenerative Medicine Advocate Network
-
Eric Drew posted an update in the group Regenerative Medicine Advocate Network
Companies selling risky stem cell products receive FDA warningThe FDA have issued warnings to several companies marketing potentially unsafe products involving stem cells and other cellular material. -
Marc posted an update in the group Regenerative Medicine Advocate Network
Whatever you think you know about stem cells, it is yesterday’s science. There is a different stem cell discovered but relatively unknown despite of hundreds of publications, peer review, FDA IRBs, we are still basically unknown. What we discovered and patented are a group of adult telomerase positive stem cells. Telomerase POSTIVE means the is no hayflick limit, i.e, these cells are known as Immortal cells and are the basis of true anti-aging and regeneration. That one of our cells is Totipotent means, unlike Pluripotent cells they can become ANY cell in the body including sperm and ova. They become whatever is necessary, unlike IPS WITHOUT modification or inducement. Therefore the are zero teratomas. Unlike there is a genetic defect, we utilize autologous cells and therefore no immune rejection. We have successfully treated 100s of patients with a multitude of morbidities including regeneration of to patients with MIs of less than 25 and now are off the transplant list. I am seeking clinics interested in bring our treatments to their local markets. Our our research and patient treatments are backed by FDA monitoring and IRBs. One more key attribute of our unique protocol is that we are able to accomplish treatment in many cases with ONLY nutraceuticals, ie without isolation. Where more aggressive treatment is recommended with utilize additional blood draw, proliferation and re-insertion within typically 24 hours or less. Marc S. Nehamkin, CEO TotiMed Global Group. 408-202-3931
Totimed | Science & Naure Applied to LifeTotiMed is changing how stem cells will be utilized by offering the world’s only source of non-embyonic totipotent stems cells for the non-invasive treatment of a myriad of medical conditions and diseases. -
Marc joined the group Regenerative Medicine Advocate Network
-
Daniel Christian Patient Advocate joined the group Regenerative Medicine Advocate Network
-
Daniel Christian Patient Advocate joined the group Regenerative Medicine Advocate Network
-
Jane joined the group Regenerative Medicine Advocate Network
-
Ericdrew18 joined the group Regenerative Medicine Advocate Network
-
Eric Drew joined the group Regenerative Medicine Advocate Network